Zobrazeno 1 - 10
of 122
pro vyhledávání: '"EsophyX"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
David P, Lee, Kenneth J, Chang
Publikováno v:
Digestive diseases and sciences, vol 67, iss 5
Gastroesophageal reflux disease (GERD) has consistently been the most frequently diagnosed gastrointestinal malady in the USA. The mainstay of therapy has traditionally been medical management, including lifestyle and dietary modifications as well as
Autor:
Karim S. Trad
Publikováno v:
Current Opinion in Gastroenterology
Purpose of review Transoral incisionless fundoplication (TIF) performed with the EsophyX device (Redmond, Washington, USA) is a totally endoscopic procedure with the objectives to mechanically repair a defective gastroesophageal valve and to reduce s
Autor:
Jeffrey A. Heise, Mark A. Fox, Gilbert Simoni, Mamoon Raza, Peter G. Mavrelis, Jennifer A Steffen, Ahmad B. Shughoury, Karim S. Trad, William E. Barnes, Elizabeth R Prevou
Publikováno v:
Surgical Innovation
Background. Questions remain about the therapeutic durability of transoral incisionless fundoplication (TIF). In this study, clinical outcomes were evaluated at 5 years post-TIF 2.0. Methods. A total of 63 chronic gastroesophageal reflux disease (GER
Publikováno v:
Journal of Surgical Case Reports, Iss 5, p 1 (2010)
An estimated 10 billion dollars is spent treating gastro-oesophageal reflux disease (GERD) in the USA every year. The present article reports a case of the safe and successful use of transoral incisionless fundoplication (TIF) using the EsophyX™ de
Externí odkaz:
https://doaj.org/article/314491997dcf4855a86ee3f8f6de45b0
Autor:
Trad, Karim S., Barnes, William E., Simoni, Gilbert, Shughoury, Ahmad B., Mavrelis, Peter G., Raza, Mamoon, Heise, Jeffrey A., Turgeon, Daniel G., Fox, Mark A.
Publikováno v:
Surgical Innovation
Background. Incomplete control of troublesome regurgitation and extraesophageal manifestations of chronic gastroesophageal reflux disease (GERD) is a known limitation of proton pump inhibitor (PPI) therapy. This multicenter randomized study compared
Autor:
He, Suyu
Background: Endoluminal sphincter augmentation (ESA) can be a choice for selected patients with gastroesophageal reflux disease (GERD). Methods: ESA using EsophyX or GERDX were performed in 36 patients. PPI usage and GERD-related symptom were evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______518::cdadbe7c56432b03e30d7c62cb447592
https://mediatum.ub.tum.de/doc/1362502/document.pdf
https://mediatum.ub.tum.de/doc/1362502/document.pdf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Gastro-esophageal reflux disease (GERD) is a very common disorder that results primarily from the loss of an effective antireflux barrier, which forms a mechanical obstacle to the retrograde movement of gastric content. GERD can be currently treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfdc2f6f3d3235fdb412cb4eca4f39e1
https://europepmc.org/articles/PMC4848240/
https://europepmc.org/articles/PMC4848240/
Publikováno v:
Surgical Endoscopy
Background Laparoscopic revision of failed traditional fundoplication is difficult and involves risk of gastric, esophageal, and vagal nerve injury that is higher than that of the primary fundoplication. This study assessed feasibility and clinical o